US speeds research into mind-altering drugs — including mysterious 'ibogaine'

The US has issued an executive order to accelerate research on mind-altering drugs, including ibogaine, a psychedelic substance. While some researchers welcome the move, others caution that careful oversight is necessary to ensure safety and efficacy.